Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients.

BACKGROUND: To evaluate the clinical features, treatment results, prognostic factors and late toxicities of nasopharyngeal carcinoma in children and adolescents.

METHODS: Between January 1990 and January 2011, 158 NPC patients younger than 20 years old were treated in our institution, and the patient's clinical characteristics, treatment modalities, outcomes and prognostic factors were retrospectively analyzed.

RESULTS: There were 9 (5.7%) patients in stage II, 60 (38.0%) in stage III and 89 (56.3%) in stage IV according to the UICC2002 staging system. Neck mass (32.3%), headache (21.5%) and nasal obstruction (15.2%) were the most common chief complaints. With a median follow-up time of 62.5 months (range 2.0-225.0 months), the 5-year overall survival (OS) rate, local-regional control (LRC) rate and distant metastasis-free survival (DMFS) rate were 82.6%, 94.9% and 76.4%, respectively. There were 43 (27.2%) patients failed during the follow up, with seven local-regional recurrences and 38 distant metastases. In univariate analysis, the 5-year OS of T4 and T1-3 were 75% and 87.9%, p=0.01, stage IV and stage II-III were 77.1% and 90%, p=0.04, respectively. In multivariate analysis, T4 (p=0.02) and stage IV (p=0.04) were the independent adverse prognostic factors for OS. Significant reduction in trismus (27.3% v 3.6%, p=0.03) and G2 xerostomia (37.9% v 10.3%, p=0.02) was observed in patients treated by IMRT.

CONCLUSIONS: Most childhood and adolescence nasopharyngeal carcinoma patients were locally advanced diseases at first diagnosed. The treatment results of radiotherapy, with or without chemotherapy, are excellent in our institution. Reducing distant metastasis with new strategies and late toxicities with intensity-modulated radiotherapy are the future directions for the treatment of adolescent nasopharyngeal carcinoma.